We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.85B
Cap. Flow %
-89.66%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.1 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.1 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Top Buys

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$604M
2
SPLK icon
Splunk Inc
SPLK
+$446M
3
HES icon
Hess
HES
+$339M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$106M
5
X icon
US Steel
X
+$50.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.06B
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$887M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$371M
4
VMW
VMware, Inc
VMW
+$354M
5
NEWR
New Relic, Inc.
NEWR
+$284M

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Miscellaneous 10.26%
5 Real Estate 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ATRC icon
351
AtriCure
ATRC
$2.84B
$435K 0.01%
12,199
-37,094
-75% -$1.38M
2022 Q3
5 quarters
SCYX icon
352
SCYNEXIS
SCYX
$40.6M
$423K 0.01%
23,683
-22,069
-48% -$324K
2022 Q2
6 quarters
LCID icon
353
Lucid Motors
LCID
$1.49B
$421K 0.01%
+10,000
New +$449K
2023 Q4
0 quarters
VKTX icon
354
Viking Therapeutics
VKTX
$3.63B
$412K 0.01%
22,141
-35,764
-62% -$468K
2022 Q3
5 quarters
NERV icon
355
Minerva Neurosciences
NERV
$152M
$398K 0.01%
64,644
-5,356
-8% -$30.6K
2023 Q3
1 quarter
PHAT icon
356
Phathom Pharmaceuticals
PHAT
$587M
$394K 0.01%
43,209
-74,071
-63% -$638K
2022 Q1
7 quarters
MARA icon
357
Marathon Digital Holdings
MARA
$3.73B
$393K 0.01%
+16,749
New +$211K
2023 Q4
0 quarters
PMVP icon
358
PMV Pharmaceuticals
PMVP
$81.3M
$391K 0.01%
+126,000
New +$333K
2023 Q4
0 quarters
CYTK icon
359
CALL
Cytokinetics
CYTK
$8.75B
$387K 0.01%
+10,000
New +$362K
2023 Q4
0 quarters
ALT icon
360
Altimmune
ALT
$508M
$386K 0.01%
+34,298
New +$143K
2023 Q4
0 quarters
EVLVW icon
361
DELISTED
Evolv Technologies Warrant
EVLVW
$380K 0.01%
478,241
-214,959
-31% -$139K
2021 Q3
9 quarters
TSLA icon
362
Tesla
TSLA
$1.51T
$373K 0.01%
1,500
-1,000
-40% -$238K
2021 Q2
10 quarters
BCRX icon
363
BioCryst Pharmaceuticals
BCRX
$2.18B
$360K 0.01%
60,159
-181,661
-75% -$1.05M
2022 Q1
7 quarters
CRNX icon
364
DELISTED
Crinetics Pharmaceuticals
CRNX
$357K 0.01%
10,038
-16,115
-62% -$494K
2022 Q1
7 quarters
CCL icon
365
PUT
Carnival Corporation Ltd
CCL
$35.4B
$347K 0.01%
1,021,500
+106,500
+12% +$1.55M
2021 Q3
9 quarters
IMCR icon
366
CALL
Immunocore
IMCR
$1.51B
$340K 0.01%
+25,000
New +$1.3M
2023 Q4
0 quarters
CNTX icon
367
Context Therapeutics
CNTX
$27.9M
$335K 0.01%
296,675
+975
+0.3% +$1.05K
2023 Q2
2 quarters
IFRX icon
368
InflaRx
IFRX
$236M
$329K 0.01%
201,880
-188,120
-48% -$322K
2023 Q2
2 quarters
SNDX icon
369
CALL
Syndax Pharmaceuticals
SNDX
$1.52B
$326K 0.01%
75,000
-5,000
-6% -$76.9K
2023 Q3
1 quarter
XRX icon
370
PUT
Xerox
XRX
$361M
$307K 0.01%
248,800
– –
2021 Q2
10 quarters
DCPH icon
371
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$290K 0.01%
120,000
+70,000
+140% +$893K
2023 Q3
1 quarter
ASAN icon
372
Asana
ASAN
$2.31B
$285K 0.01%
15,000
-70,000
-82% -$1.36M
2023 Q1
3 quarters
CHGG icon
373
Chegg
CHGG
$81.7M
$284K 0.01%
25,000
– –
2023 Q1
3 quarters
FAF icon
374
First American
FAF
$6.25B
$269K 0.01%
+4,169
New +$238K
2023 Q4
0 quarters
SCRMW icon
375
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$262K 0.01%
+573,164
New +$91.4K
2023 Q4
0 quarters
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.